237 results on '"Duerst R"'
Search Results
2. Relative Intensity Measurements of Libs Emission Spectra of Alkali Halides and their Application to Elemental Analysis of Mineralogical Samples
3. Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant
4. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency
5. Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease
6. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The Pediatric Blood and Marrow Transplant Consortium Experience (PBMTC) 1996–2003
7. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia
8. Impact of immune modulation with anti-T cell antibodies on outcomes after unrelated donor transplantation for acute lymphoblastic leukaemia in children and adolescents: O400
9. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
10. Ionization of Strong Electrolytes. XI. The Molecular States of Nitric Acid and Perchloric Acid.
11. Registration of 'Bay' Oat
12. Registration of 'Kewaunee' Barley
13. Stem Cell Transplant (HSCT) in Pediatric CML: Is Transplantation the Standard of Care? The Children'S Memorial Hospital (CMH) Experience
14. Engraftment Kinetics in Children After Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (RIC-HSCT)
15. Nonoperative Management of Pneumatosis Intestinalis and Pneumoperitoneum in a Patient with Acute Lymphoblastic Leukemia: Case Report and Review of the Literature
16. Continuous Infusion (CI) Cyclosporine (CsA): Assessment Of Dosing In Pediatric And Adolescent Patients (PTS) With Weight>50kg During Hematopoietic Stem Cell Transplantation (HSCT)
17. Use Of “Rapid-Cycle” Failure Mode And Effects Analysis (FMEA) And Simulation To Safely Transition Hematopoietic Stem Cell (HSC) Processing Services
18. A Phase 1 Dose-Escalation Study To Evaluate The Safety And Pharmacokinetics Of Palifermin In Pediatric Subjects With Acute Leukemias Undergoing Myeloablative Therapy And Allogeneic Hematopoietic Stem Cell Transplant
19. Red Cell Content In Peripheral Hematopoietic Progenitor Cell (HPCA) Collections For Transplant In Pediatric Patients. Comparison To Adult Matched Unrelated (URD) Peripheral Blood Collections. To Determine The Maximum Acceptable Volume Of Red Cells For Infusion
20. Safety And Effectiveness Of Intravenous Pentamidine As A First Line Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis In Pediatric Patients Undergoing Allogeneic Hematopoietic Progenitor Cell Transplant (AHPCT)
21. Ambulatory Hematopoietic Stem Cell Transplant (HSCT) for Severe Primary Immunodeficiency (PID) in Children
22. Rapid Lymphocyte Recovery And Intravenous Immunoglobulin Independence In Children With Severe Combined Immunodeficiency (SCID) Undergoing Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning (RIC)
23. Significance Of HLA-B Antigen Matching In Event Free Survival (EFS) In Pediatric Umbilical Cord Blood Transplantation (CBT): Experience from 124 Single CBT At Children's Memorial Hospital (CMH), CHICAGO
24. Preengraftment C-Reactive Protein Predicts Infection Risk and Nonrelapse Mortality in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
25. Growth and CGVHD In Pediatric Patients Undergoing Reduced Intensity Conditioning for Hematopoietic Stem Cell Transplant As Compared to Traditional Myeloablative Conditioning
26. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency
27. 201: Extracorporeal Photopheresis (ECP) is an Effective Therapy for the Treatment of Children with Steroid Refractory (SR) Chronic Graft vs Host Disease (cGVHD)
28. 222: Donor Chimerism Kinetics in Pediatric Patients Undergoing Reduced Intensity Conditioning (RIC) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
29. 255: Correlation between infused mononuclear cells (MNC) and transplant outcome in pediatric cord blood transplantation (CBT). A study of 92 single CBT done at Children’s Memorial Hospital, Chicago, IL
30. 176: Reduced intensity conditioning (RIC) and hematopoietic stem cell transplantatiation (HSCT) using photopheresis (ECP), fludarabine, and targeted single dose busulfan as an outpatient procedure in children
31. 23. Outcomes of unrelated cord blood transplants and allogeneic related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia
32. Weight loss in pediatric patients with chronic graft-versus-host disease (cGVHD)
33. Umbilical Cord Blood Transplants (UCBT). Evaluation of chimerism and survival in relation to CD34 or mononuclear cell (MNC) dose infused. The Children’s Memorial Hospital (CMH) experience
34. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The Pediatric Blood and Marrow Transplant Consortium Experience (PBMTC) 1996–2003
35. Outcomes of UCB (unrelated cord blood) transplantation are equivalent to matched-sibling hematopoietic stem cell transplantation (HSCT) in children with high-risk acute lymphocytic leukemia (ALL)
36. Comparison of outcomes after transplantation of unrelated donor umbilical cord blood versus matched sibling bone marrow for pediatric patients with leukemia and myelodysplastic syndromes
37. Reduced intensity (RI) conditioning and allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with non-malignant disorders
38. A test dose of I.V. busulfan (BU) is predictive of the area under the curve (AUC) of a single daily dose of I.V. bu in pediatric patients undergoing a reduced intensity (RI) hematopoietic stem cell transplant (HSCT)
39. Therapy of myeloid leukemias with autotransplantation followed by immunotherapy
40. Registration of ‘Gem’ Oat
41. Free radicals trapped in polyethylene crystals
42. One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.
43. Polymer drying. VI. EPR spin-probe studies on swelled poly(styrene-co-divinylbenzene)
44. Registration of ‘Horicon’ Oat
45. Registration of ‘Wright’ Oat
46. Registration of ‘DAL’ Oat
47. Registration of ‘Centennial’ Oat
48. Registration of ‘Goodland’ Oat
49. Registration of ‘Froker’ Oat
50. Promising Outcomes with Tandem Autologous Stem Cell Rescue in ‘Late’ Wilms Tumor Relapse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.